Zenas BioPharma
Steve Ryan is an experienced regulatory operations professional with a career spanning over two decades in the biopharmaceutical industry. Currently serving as Senior Director of Regulatory Operations at Zenas BioPharma since March 2024, Steve has a strong history of managing regulatory submissions and systems across various organizations. Previous roles include Director of Regulatory Operations at Beam Therapeutics and Foghorn Therapeutics, where responsibilities included submission management, Veeva RIM implementation, and collaboration with cross-functional teams. Steve's expertise includes extensive experience with FDA submissions and regulatory requirements, having also contributed to key projects at companies such as Blueprint Medicines, Wave Life Sciences, Sage Therapeutics, Alnylam Pharmaceuticals, Cubist Pharmaceuticals, and Genzyme Corporation. Steve holds an Associate in Applied Science degree in Industrial Design from Wentworth Institute of Technology.
This person is not in any teams
This person is not in any offices
Zenas BioPharma
6 followers
Zenas BioPharma is a cross-border (China-USA-based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune-based therapies for patients in China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through its successful business development strategy.